The latest report by IMARC Group, titled “Patient Centric Healthcare App Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The global patient centric healthcare app market size reached US$ 10.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 32.4 Billion by 2028, exhibiting a growth rate (CAGR) of 20.5% during 2023-2028.
A patient-centric healthcare app provides numerous health-related services to patients who can avail them via their smartphones or tablets. Patients can use the app to monitor various aspects of their health, such as weight, calorie intake, blood glucose levels, hydration, and daily physical activity. These apps also aid in managing chronic diseases, such as diabetes, cancer, and hypertension, and facilitate electronic data interchange (EDI) with clinicians. Since there has been a rise in the use of telehealth/telemedicine due to the recent coronavirus disease (COVID-19) outbreak, patient-centric healthcare apps are gaining immense traction across the globe.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/patient-centric-healthcare-app-market/requestsample
Patient Centric Healthcare App Market Trends and Drivers:
The global patient centric healthcare app market is primarily driven by the increasing reliance on smartphones and other electronic devices. Moreover, healthcare experts are collaborating with mobile app developers to create intuitive patient-centric healthcare apps that offer uninterrupted access even without an active internet connection, which in turn is positively influencing the market growth. Additionally, the rising use of patient-centric healthcare apps by cancer patients to manage their medications, track treatment progress, monitor side effects, and schedule follow-up appointments has catalyzed market growth. Furthermore, numerous advancements in information technology (IT) that are transforming healthcare delivery and patient education are contributing to the market growth. Other factors, including the increasing geriatric population, the surging demand for wearable devices, and growing health consciousness among individuals, are also anticipated to drive the market further.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Technology:
- Phone-Based Apps
- Web-Based Apps
- Wearable Patient Centric Apps
Breakup by Operating System:
- iOS
- Android
- Windows
- Others
Breakup by Application:
- Wellness Management
- Disease and Treatment Management
Breakup by End User:
- Hospitals
- Clinics
- Home Use
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Allscripts Healthcare Solutions Inc.
- Athenahealth Inc.
- Bayer Aktiengesellschaft
- Boston Scientific Corporation
- Hill-Rom Services Inc. (Baxter International Inc.)
- iPatientCare LLC
- Koninklijke Philips N.V.
- Merck & Co. Inc.
- Mobilesmith Inc.
- Pfizer Inc.
- Siemens Healthineers AG (Siemens AG)
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163
